Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Feb. 4, 2014

View Archived Issues

Washington roundup: VAD readmissions hold steady despite rising COPD, atrial fib

FDA clears PillCam COLON for following incomplete colonoscopy

Grants roundup: Tasso simplifies blood sampling, secures $2.3 million in funding

Financings roundup: MELA Sciences reports details of its recent private placement

Agreements/contracts: Definiens extends testing collaboration with Clarient

HIT roundup: Telemedicine app helps prevent unnecessary CT scans in kids

Products

People in Places

MDD's Cardiology Extra

Deals roundup: Smith & Nephew in bid to acquire ArthroCare for $1.7 billion in cash

Smith & Nephew (S&N; London) reported the execution of a definitive agreement to acquire ArthroCare (Austin) for about $1.7 billion. Read More

Report from Europe: GI's EndoBarrier received into German reimbursement system

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...